Abstract: A control module for an air treatment system of a utility vehicle comprises the following: a first and second pneumatic magnetic valve having a first or second coil, connecting pins, and armatures accommodated in the coils, a circuit carrier, and a module housing that is cast from a plastic material, into which housing the coils are cast. The connecting pins project from a first side of the module housing and are electrically connected to the circuit carrier. A plug-in connection for receiving a connection plug is formed in the module housing, wherein the plug-in connection has plug-in pins, which extend through the module housing and are electrically connected to the circuit carrier. The module housing has a mounting surface having pneumatic connections for installation on an air dryer housing of an air dryer.

Abstract: A device for acquiring and processing sensor measured values and/or for controlling actuators has a base housing, sensors and/or actuators attached to the base housing, a cover that can be connected to the base housing to cover the sensors and/or actuators, and a circuit board with control electronics. To mount the circuit board easily and effect secure contact of the sensors therewith, the circuit board is securely connected to the inner side of the cover using press-fit connectors, the circuit board has electrically active first contact faces on its side remote from the cover, the sensors and/or actuators have electrically active second contact faces on their sides facing the cover, and the second contact faces of the sensors and/or actuators are connected to the first contact faces via electrically conductive contact springs.

Abstract: A device for acquiring and processing sensor measured values and/or for controlling actuators has a base housing, sensors and/or actuators attached to the base housing, a cover that can be connected to the base housing to cover the sensors and/or actuators, and a circuit board with control electronics. To mount the circuit board easily and effect secure contact of the sensors therewith, the circuit board is securely connected to the inner side of the cover using press-fit connectors, the circuit board has electrically active first contact faces on its side remote from the cover, the sensors and/or actuators have electrically active second contact faces on their sides facing the cover, and the second contact faces of the sensors and/or actuators are connected to the first contact faces via electrically conductive contact springs.

Abstract: A display system is provided for a trailer equipped with an electronic braking system (EBS) and/or an anti-lock braking system (ABS). A separate display device having a display is provided for indicating at least the mileage on the trailer vehicle. In order to reduce the amount of wiring required, a speed signal of at least one of the wheels of the trailer is looped through the EBS/ABS and is routed directly to the display device.

Abstract: Disclosed are compounds of formula (I): wherein R3, R5, R7 and R8 are defined herein, which are useful as inhibitors SYK kinase and are thus useful for treating diseases resulting from inappropriate mast cell activation, which include allergic and inflammatory diseases. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.

Abstract: A display system is provided for a trailer equipped with an electronic braking system (EBS) and/or an anti-lock braking system (ABS). A separate display device having a display is provided for indicating at least the mileage on the trailer vehicle. In order to reduce the amount of wiring required, a speed signal of at least one of the wheels of the trailer is looped through the EBS/ABS and is routed directly to the display device.

Abstract: Disclosed are compounds of formula (I): wherein R3, R5, R7 and R8 are defined herein, which are useful as inhibitors SYK kinase and are thus useful for treating diseases resulting from inappropriate mast cell activation, which include allergic and inflammatory diseases. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.

Abstract: Disclosed are compounds of formula (I): wherein R3, R5, R7 and R8 are defined herein, which are useful as inhibitors SYK kinase and are thus useful for treating diseases resulting from inappropriate mast cell activation, which include allergic and inflammatory diseases. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.

Abstract: Disclosed are compounds of formula (I): wherein R3, R5, R7 and R8 are defined herein, which are useful as inhibitors SYK kinase and are thus useful for treating diseases resulting from inappropriate mast cell activation, which include allergic and inflammatory diseases. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.

Abstract: Disclosed are compounds of formula (I): wherein R3, R5, R7 and R8 are defined herein, which are useful as inhibitors SYK kinase and are thus useful for treating diseases resulting from inappropriate mast cell activation, which include allergic and inflammatory diseases. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.

Abstract: Disclosed are compounds of formula (I): 1

Abstract: Disclosed are compounds of formula (I): 1

Abstract: Disclosed are new cyclic amine derivatives of the formula I ##STR1## wherein the substituents are defined in the specification. These compounds are useful as for treating sinus tachycardia.

Abstract: The present invention relates to new heteroaromatic amine derivatives of general formula ##STR1## wherein the substituents are defined hereinbelow, which have valuable pharmacological properties, particularly a heart rate lowering activity and a positive inotropic activity.

Abstract: The present invention relates to new heteroaromatic amine derivatives of general formula ##STR1## wherein the substituents are defined hereinbelow, which have valuable pharmacological properties, particularly a heart rate lowering activity and a positive inotropic activity.

Abstract: The present invention relates to new naphthyl derivatives of general formula ##STR1## wherein N represents the number 1 or 2,A represents a --CH.sub.2 --, --CO--, --CH.sub.2 CH.sub.2 --, --CH.dbd.CH--, ##STR2## while the atom marked with an x is linked to the phenyl nucleus, E represents a straight chained alkylene group optionally substituted by an alkyl group,G represents a straight chained alkylene group optionally substituted by an alkyl group,L represents a bond or an oxygen atom, if G represents a straight chained alkylene group with 2 to 5 carbon atoms optionally substituted by an alkyl group,R.sub.1 and R.sub.2, which may be identical or different, represent alkyl or alkoxy groups or R.sub.1 and R.sub.2 together represent an alkylenedioxy group,R.sub.3 represents a hydrogen atom, or an alkyl or an allyl group,R.sub.4, R.sub.5 and R.sub.

Abstract: The invention relates to new imidazo-benzoxazinones of formula ##STR1## wherein the substituents are defined herein below, which compounds are useful in the treatment of cardiovascular disorders.

Abstract: Compounds of the formula ##STR1## wherein A, B, C and D are --N.dbd., HN.dbd., R.sub.3 N.dbd., O.dbd.C.dbd., HC.tbd., HO--C.tbd. or R.sub.3 SO.sub.2 --O--C.tbd.; andR.sub.1 and R.sub.2 are substituents of various types.The compounds are useful as hypotensives and cardiotonics.

Abstract: Compounds of the formula ##STR1## wherein A, B, C and D are each independently --N.dbd. or --CH.dbd., provided, however, that at least two of them must be --N.dbd., and when A and C are both --N.dbd., at least one or both of B and D must be --N.dbd.; andR.sub.1, R.sub.2 and R.sub.3 are substituents of diverse types;tautomers thereof; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds are useful as cardiotonics.

Abstract: The invention relates to new heteroaromatic amine derivatives of formula ##STR1## wherein A represents a --CH.sub.2 --CH.sub.2 --, --CH.dbd.CH--or ##STR2## group and B represents a methylene, carbonyl or thiocarbonyl group or A represents a --CO--CO or ##STR3## group and B represents a methylene group, in which the carbon atom marked x is linked to the phenyl nucleus,E represents a straight-chained alkylene group optionally substituted by an alkyl group,G represents a straight-chained alkylene group optionally substituted by an alkyl group,R.sub.1 represents a hydrogen, fluorine, chlorine or bromine atom, a trifluoromethyl, nitro, amino, alkylamino, dialkylamino, alkyl, alkylmercapto, hydroxy, alkoxy or phenylalkoxy group,R.sub.2 represents a hydrogen, chlorine or bromine atom or a hydroxy, alkoxy, phenylalkoxy or alkyl group orR.sub.1 and R.sub.2 together represent an alkylenedioxy group,R.sub.